ArticleBMC ophthalmology2023

Baseline characteristics and treatment response predictive of nAMD outcomes with ranibizumab therapy in treatment-naive patients: the RACER subgroup analysis.

Ching-Yao Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.